SCHEMBL32669229

SCHEMBL32669229

COC(=O)Cc1cc(N)c(F)c(Br)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
GAA P10253 3/20 0.53
GFER P55789 1/20 0.53
HSP90AB1 P08238 1/20 0.49
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.39
SLC7A5 Q01650 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
TP53 P04637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
THRB P10828 3/20 0.36
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
MEN1 O00255 1/20 0.35
F2 P00734 1/20 0.34
F10 P00742 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21804721 0.84 HSP90AB1 (0.51) ALDH1A1GAAGFERHSP90AB1CYP4F2
SCHEMBL30393854 0.82 HSP90AB1 (0.56) ALDH1A1GAAGFERHSP90AB1CYP4F2
SCHEMBL5156427 0.78 ALDH1A1 (0.64) ALDH1A1GAAGFERHSP90AB1CYP4F2
SCHEMBL29518485 0.78 ALDH1A1 (0.64) ALDH1A1GAAGFERHSP90AB1CYP4F2
SCHEMBL5093783 0.76 ALDH1A1 (0.67) ALDH1A1GAAGFERHSP90AB1CYP4F2
SCHEMBL2786552 0.76 HSP90AB1 (0.63) ALDH1A1GAAGFERHSP90AB1CYP4F2
SCHEMBL12678868 0.76 HSP90AB1 (0.58) ALDH1A1GAAGFERHSP90AB1CYP4F2
SCHEMBL31075998 0.76 HSP90AB1 (0.54) ALDH1A1GAAGFERHSP90AB1CYP4F2
SCHEMBL31075734 0.75 HSP90AB1 (0.49) ALDH1A1GAAGFERHSP90AB1CYP4F2
SCHEMBL23380842 0.75 HSP90AB1 (0.56) ALDH1A1GAAGFERHSP90AB1CYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260034126-A1 KRAS INHIBITORS INCYTE CORP (US) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034126-A1 KRAS INHIBITORS KRAS, NRAS, HRAS ALDH1A1 3023/4885GAA 4419/4885GFER 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.